Fluoropharma Medical Stock Filter Stocks by Fundamentals
| FPMI Stock | USD 0.0001 0.00 0.00% |
Fluoropharma Medical fundamentals help investors to digest information that contributes to Fluoropharma Medical's financial success or failures. It also enables traders to predict the movement of Fluoropharma Pink Sheet. The fundamental analysis module provides a way to measure Fluoropharma Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Fluoropharma Medical pink sheet.
Fluoropharma |
Did you try this?
Run Portfolio File Import Now
Portfolio File ImportQuickly import all of your third-party portfolios from your local drive in csv format |
| All Next | Launch Module |
Fluoropharma Fundamentals
| Return On Asset | -2.35 | |||
| Current Valuation | 9.23 M | |||
| Shares Outstanding | 34.26 M | |||
| Shares Owned By Institutions | 0.34 % | |||
| Price To Earning | (0.39) X | |||
| Price To Book | 17.76 X | |||
| EBITDA | (2.16 M) | |||
| Net Income | (2.05 M) | |||
| Cash And Equivalents | 24.72 K | |||
| Total Debt | 5.82 M | |||
| Debt To Equity | 0.07 % | |||
| Book Value Per Share | (0.30) X | |||
| Cash Flow From Operations | (880.12 K) | |||
| Earnings Per Share | (0.08) X | |||
| Target Price | 2.5 | |||
| Beta | -59.92 | |||
| Market Capitalization | 3.43 M | |||
| Total Asset | 334.76 K | |||
| Retained Earnings | (34.16 M) | |||
| Working Capital | (10.23 M) | |||
| Current Asset | 89 K | |||
| Current Liabilities | 10.32 M | |||
| Net Asset | 334.76 K |
About Fluoropharma Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Fluoropharma Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Fluoropharma Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Fluoropharma Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Fluoropharma Pink Sheet
Fluoropharma Medical financial ratios help investors to determine whether Fluoropharma Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Fluoropharma with respect to the benefits of owning Fluoropharma Medical security.